» Articles » PMID: 10400674

Identification of the Erythropoietin Receptor Domain Required for Calcium Channel Activation

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1999 Jul 10
PMID 10400674
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Erythropoietin (Epo) activates a voltage-independent Ca2+ channel that is dependent on tyrosine phosphorylation. To identify the domain(s) of the Epo receptor (Epo-R) required for Epo-induced Ca2+ influx, Chinese hamster ovary (CHO) cells were transfected with wild-type or mutant Epo receptors subcloned into pTracer-cytomegalovirus vector. This vector contains an SV40 early promoter, which drives expression of the green fluorescent protein (GFP) gene, and a cytomegalovirus immediate-early promoter driving expression of the Epo-R. Successful transfection was verified in single cells by detection of GFP, and intracellular Ca2+ ([Ca]i) changes were simultaneously monitored with rhod-2. Transfection of CHO cells with pTracer encoding wild-type Epo-R, but not pTracer alone, resulted in an Epo-induced [Ca]i increase that was abolished in cells transfected with Epo-R F8 (all eight cytoplasmic tyrosines substituted). Transfection with carboxyl-terminal deletion mutants indicated that removal of the terminal four tyrosine phosphorylation sites, but not the tyrosine at position 479, abolished Epo-induced [Ca]i increase, suggesting that tyrosines at positions 443, 460, and/or 464 are important. In CHO cells transfected with mutant Epo-R in which phenylalanine was substituted for individual tyrosines, a significant increase in [Ca]i was observed with mutants Epo-R Y443F and Epo-R Y464F. The rise in [Ca]i was abolished in cells transfected with Epo-R Y460F. Results were confirmed with CHO cells transfected with plasmids expressing Epo-R mutants in which individual tyrosines were added back to Epo-R F8 and in stably transfected Ba/F3 cells. These results demonstrate a critical role for the Epo-R cytoplasmic tyrosine 460 in Epo-stimulated Ca2+ influx.

Citing Articles

Systematic Review of Erythropoietin (EPO) for Neuroprotection in Human Studies.

Hemani S, Lane O, Agarwal S, Yu S, Woodbury A Neurochem Res. 2021; 46(4):732-739.

PMID: 33521906 DOI: 10.1007/s11064-021-03242-z.


Erythropoietin Receptor Antagonist Suppressed Ectopic Hemoglobin Synthesis in Xenografts of HeLa Cells to Promote Their Destruction.

Yasuda Y, Fujita M, Koike E, Obata K, Shiota M, Kotani Y PLoS One. 2015; 10(4):e0122458.

PMID: 25874769 PMC: 4398449. DOI: 10.1371/journal.pone.0122458.


A splice variant of the human ion channel TRPM2 modulates neuroblastoma tumor growth through hypoxia-inducible factor (HIF)-1/2α.

Chen S, Hoffman N, Shanmughapriya S, Bao L, Keefer K, Conrad K J Biol Chem. 2014; 289(52):36284-302.

PMID: 25391657 PMC: 4276889. DOI: 10.1074/jbc.M114.620922.


Role of TRPM2 in cell proliferation and susceptibility to oxidative stress.

Chen S, Zhang W, Tong Q, Conrad K, Hirschler-Laszkiewicz I, Bayerl M Am J Physiol Cell Physiol. 2013; 304(6):C548-60.

PMID: 23302782 PMC: 3671566. DOI: 10.1152/ajpcell.00069.2012.


The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor.

Javadi M, Hofstatter E, Stickle N, Beattie B, Jaster R, Carter-Su C J Biol Chem. 2012; 287(31):26223-34.

PMID: 22669948 PMC: 3406707. DOI: 10.1074/jbc.M112.382721.